Although melanoma accounts f or approximately 1% of all malignancies, me lanoma metastases to the cerebellopontin e angles (CPAs) are exceedingly rare. Here we describe a patient with melan oma metastases to the internal auditory canals and CPAs who presented with a remote history of cutan eous melanoma. This patient had a rapidly progressive hearin g loss, vestibulopathy, and f acial nerve dysfun ction. Magnetic resonan ce imagin g demonstrated bilateral, enhancing CPA lesions but was othenvise nonspecific. The diagnosis required a careful history, unilateral surgical resectionfor tissue acquisition, and histopatholo gic confi rmation. A search for primary cutaneo us melan oma at the time of presentation was negative. However; the history of cutaneo us melanoma 8 years earlier distin guishes this pati ent's metastati c diseasefrom solitary primary intra cranial melan oma , an equally rare disease. Treatm ent consists of surgical excision, radiation, chemothe rapy, and immunotherapy. The progno sis for pati ents with melan oma metastases is generally p oor; but isolated reports of long-term survival hav e been described. Metastatic dis ease to the CPAs must be included in the differential diagnosisfo r any patient pres enting with rapid-onset Vllth or VJJ1th cranial nerve symptoms.
Introduction
Malignant melanoma repre sents approximately I% of all malignancies.I The most common sites for spread are the lung, brain , liver, gastroint estinal tract , and bone , but melanoma is also the third most common metast atic lesion to the central nervous system (CNS). Autopsy studies on patients with meta static melanom a have found melanoma From metastases in the brain in 17.5 to 90% of cases. I CNS melanoma tends to be diffuse, and patient survival is typically less than 3 months.' In reviewin g more than 1,000 cases of cerebellopontine angle (CPA) tumor, Brackmann and Bartels found only 3 lesions (0.2%) of metastatic origin. ' A search of the literature through March 2005 located 8 cases of meta static melanoma isolated to the intern al auditory canal (lAC) and CPA, 3 of which involved the IACs/CPAs bilaterally." :" Since that time, a review of the House Ear Institute experience identified 8 additional patients with CPA melanom a; 4 had bilateral disea se. " Therefore, we report the eighth such case with bilateral melanoma metastases filling the lAC s and extending into the CPAs. Within 2 month s of presentation, the CNS was diffusely involved.
Case report
A 56-year-old man presented to the local emergency department with a l-day history of left facial weakness and numbnes s. He also described several days of generalized weakness, chills, and malaise before the onse t of facia l palsy. The patient's medical history was sign ificant for diabetes, hypertension, hyperlipidemia, hemorrhoidectomy, and a cutaneous melanoma excised from his back 8 years earlier.
Except for a mildl y elevated blood gluco se level , results of the patient 's laboratory tests were normal , as were his vital signs. Noncontrast computed tomography (CT) of the head demonstrated no acute pathology, and the patient was discharged from the hospital with a diagno sis of Bell's palsy. He was started on oral steroids and acyclovir.Within 2 weeks, however, he progressed to bilateral facial weakness and hypesthe sia.
Outpatient magnetic resonance imaging (MRI) of the brain (figure I) was obtained by the con sultin g neurosurgical team. Th is study dem onstrated bilateral enhanc ing masses in the patient's lAC s and CPAs. No other intracranial lesions were found . The patient was referred to our clinic for consultation and furthe r managemen t.
During our initial evaluation, the patien t was found to have bilateral facial paresi s and hypesthesia.An audiogram was obtained, and speech discrimination scores were 100% The patient underwent a translabyrinthine excision of the left CPA mass . During surgery, the tumor was found to be soft and friable with no obvious capsule. The VIIth and VIIIth cranial nerves were engulfed by the mass except laterally in the lAC and again medially at the brainstem, where each could be identified distinctly. Involved portions of the facial nerve were resected in continuity with the tumor. The tympanic and labyrinthine segments of nerve were then rerouted and a primary anastomosis was performed on the brainstem remnant.
Histopathologic examination of the specimen (figure 2) revealed large, pleomorphic polygonal cells with prominent nuclei. These cells were positive for S-I00 protein and demonstrated greater than a 50% proliferative index by Ki67 immunohistochemistry. These findings were consistent with the histopathology of the cutaneous melanoma excised from the patient's back 8 years earlier.
By postoperative day 3, the patient began complaining of severe frontal headaches. He was hyponatremic as a result ofSIADH (syndrome of inappropriate antidiuretic hormone secretion) and had mild pulmonary edema. CT of the chest , abdomen, and pelvis failed to reveal any obvious signs of malignancy. A bone scan was also negative. Deteriorating mental status prompted repeat head CT and MRI. The MRI now demonstrated lesions in both hypoglossal canals and several masses in the lateral ventricles in addition to the known lesion in the right CPA. A lumbar puncture was positive, with tumor cells present in the cerebrospinal fluid. Radiation and chemotherapy were recommended. Unfortunately, the patient deteriorated rapidly and died .
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Discussion
It is important to distinguish melanoma metastatic to the CPA from primary intracranial melanoma. Primary intracranial melanoma is thought to arise from melanocyte cell rests of neural crest origin that are distributed within the leptomeninges." These cells can be precursors to malignant melanoma, melanocytoma, pigmented schwannoma, and pigmented medulloblastoma. 15 Patients with primary intracranial melanoma do not have a history of cutaneous melanoma, and a thorough metastatic workup shows no evidence of a primary lesion. Mean survival ranges from 6 months in patients with diffuse leptomeningeal melanoma to 19 month s for those with solitary primary intracranial melanomas."
The typical presentation of metastatic melanoma to the lAC and CPA is rapidly progressive auditory, vestibular, and facial nerve dysfunction .These tumors infiltrate nerves rather than compressing them . Patients typically have a remote history of cutaneous melanoma, and most reported cases of solitary lAC/CPA metastases have latency periods of more than 5 years . Our patient's primary lesion-a cutaneous melanoma on his back-had been resected 8 years earlier. Unlike benign lesions of the CPA, these lesions are commonly associated with headaches, nausea, emesi s, and the involvement of other cranial nerves , such the Vth, IXth , Xth, and XIth. 5 Metastasis likely results from hematogenous seeding of the lAC with subsequent growth into the CPA. 2 Surgically obtained tissue is necessary for a histologic diagnosis, and speci al stains such as proliferation assays, S-I00 protein, and HMB-45 are needed . A complete metastatic workup-including examination of the skin and mucous membranes; CT scans of the chest , abdomen, and pelvis ; and a bone scan-should be performed. There is an emerging role for positron-emission tomography in the workup of malignant melanoma. 16.17 The literature indicates that intracranial melanoma has varied MRl findin gs. Shortening of T l and T2 relaxation times may be most characteristic, but these tumors have been found to be hypointense, hyperint ense, or isointense to surrounding brain tissues.' Most lesions enh ance with gadolinium. Variation s in melanin content and the presence of blood within the tumor may affect imaging characteristics on MRI. 4Whether solitary brain melanoma lesions 390 are metastatic or primary, surgical resection palliates CNS symptoms and is thought to improve surviv al. l-Plcadiarion, chemotherapy, and immun otherap y are also recommended. While prognosis is usu ally poor, Arriag a and colleagues reported 1case with greater than 5-yearsurviva1. 4 Metastatic disease to the lAC/CPA must be included in the differential dia gno sis for any patient presentin g with rapidl y evol ving cranial neuropathie s of the lateral skull base.
